Ketamine/Betaine anhydrous

氯胺酮/无水甜菜碱

Report date: 2025/03/12 13:46:10

Base Information

Drug NameKetamine/Betaine anhydrous
Drug Alias NameKETABETKETAPATCHKETABET MN patch
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate [NMDA] receptorGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes KetamineBetaine anhydrous
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesPharmaTher Inc
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A